Results 121 to 130 of about 924 (199)

Comparative analysis of Acinetobacter baumannii bloodstream isolates from children and adults in southern China [PDF]

IntroductionAcinetobacter baumannii (A. baumannii) is a major pathogen responsible for hospital-acquired bloodstream infections, with multidrug-resistant (MDR) strains posing severe therapeutic challenges.
Cheng Li, Fan Fei, Fen Xue, Hui Xu, Nan Gao, Rui Zhao, Shuaiyuan Liang, Tiantian Zhang, Xing Wang, Xingran Du, Yanfeng Zhao   +10 more
core   +1 more source

Pneumonia pada Anak disertai Kejang Demam Kompleks [PDF]

Pneumonia in early childhood can present with systemic manifestations such as complex febrile seizures. We report the case of a 2-year-5-month-old girl who experienced two generalized seizures within 24 hours accompanied by fever, without prominent ...
Adelgrit Trisia, Sihotang, Ryan Ferdinand, Widodo, Muhammmad Noer Perdana Sakti   +2 more
core   +1 more source

Sulbactam-Durlobactam Plus Ceftriaxone Dosing and Novel Treatment Regimens for Mycobacterium abscessus Lung Disease

ABSTRACT Background IDSA guideline-based therapy achieves sputum culture conversion rates in 20-34% of patients with Mycobacterium abscessus (MAB) lung disease (LD).
Sanjay Singh, Avneesh Shrivastava, Gunavanthi D Boorgula, Mary C Long, Brian Robbins, Pamela J McShane, Tawanda Gumbo, Shashikant Srivastava   +7 more
openaire   +2 more sources

Analyzing US FDA-Approved Infectious Disease Drugs from 2015-2023 [PDF]

Primary Author: Rizamari May Pascua Co-Authors: Tracy Pham, Dianqing Sun, PhD Presentation Title: Analyzing US FDA-Approved Infectious Disease Drugs from 2015-2023 Purpose: In 2019, there are approximately 10.2 million hospital visits for infectious and ...
Rizamari May Pascua, Tracy Pham, Dianqing Sun
core   +1 more source

In vitro activity and resistance mechanisms of novel antimicrobial agents against metallo-β-lactamase producers [PDF]

Bianco, Gabriele, Boattini, Matteo, Cavallo, Rossana, Comini, Sara, Costa, Cristina   +4 more
core   +1 more source

Draft genome sequence of a KPC-2-producing, meropenem-durlobactam non-susceptible <i>Klebsiella pneumoniae</i> ST11-KL64 clinical isolate. [PDF]

Microbiol Resour Announc
Wen H, Feng Y, Zong Z.
europepmc   +1 more source

A Novel UPLC Method for the Simultaneous Estimation of Sulbactam and Durlobactam in Pharmaceutical Dosage Form

Infectious diseases especially those associated with multidrug-resistant pathogens in critically ill patients are an area of global research and concern for healthcare professionals across both the private and public sectors. Sulbactam and Durlobactam have been approved as a combination drug, called Xacdura, recently for the treatment of hospital ...
openaire   +1 more source

Disarming carbapenemase-producing <i>Acinetobacter baumannii</i>: high potency of the novel therapeutic combination of meropenem and the innovative diazabicyclooctane β-lactamase inhibitor pilabactam (formerly ANT3310). [PDF]

Antimicrob Agents Chemother
Rodríguez-Pallares S, Outeda-García M, Lence E, Rodríguez-Coello A, González-Pinto L, Guijarro-Sánchez P, Báez-Barroso GA, Blanco-Martín T, Vázquez-Ucha JC, Llanos A, Sannio F, Docquier J-D, Morrisey I, Hawser S, Zalacain M, Lemonnier M, González-Bello C, Bou G, Beceiro A, Arca-Suárez J.   +19 more
europepmc   +1 more source

Successful treatment of carbapenem-resistant <i>Acinetobacter baumannii</i> and Enterobacterales coinfection with sulbactam-durlobactam combined with aztreonam: a case report. [PDF]

AME Case Rep
Yang S, Cheng Z, Liu Y, Ni L, Wei C.
europepmc   +1 more source

In vitro activity of cefepime/zidebactam against sulbactam/durlobactam-susceptible and -resistant Acinetobacter baumannii clinical isolates. [PDF]

J Antimicrob Chemother
Tascini C, Bianco G, Bonomo RA, Gaibani P.   +3 more
europepmc   +1 more source